- Pfizer forms licensing agreement with Seattle Genetics
- Adherence among chronic disease patients can lead to big savings
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Moving PSE to Rx-only in Mo. lacks fiscal sense
FRANKLIN LAKES, N.J. — BD has introduced a needle that it said was designed to enhance adherence and comfort among patients with diabetes.
The company's BD Medical division announced the introduction of the Ultra-Fine Nano pen needle with a feature called PentaPoint Comfort technology. Most pen needles contain three bevels, but PentaPoint has a five-bevel needle tip design that creates a flatter, thinner surface to help penetrate the skin with greater ease. The company said a clinical home-use study indicated patients who used the needle reported it as less painful, easier to insert and more comfortable overall than three-bevel needles.
"We are excited to provide another first-to-market innovation, designed to dramatically improve the injection experience for the millions of people living with diabetes," BD Medical president for diabetes care Linda Tharby said. "Building on the introduction of BD's smallest needle, the BD Nano, we are confident that our new, patented PentaPoint Comfort technology will provide an even more comfortable injection experience."